Corient Private Wealth’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.1K Sell
19,837
-21,837
-52% -$57.5K ﹤0.01% 2745
2025
Q4
$145K Buy
41,674
+6,305
+18% +$42.6K ﹤0.01% 2620
2025
Q3
$316K Hold
35,369
﹤0.01% 2082
2025
Q2
$223K Sell
35,369
-2,036
-5% -$15.9K ﹤0.01% 2174
2025
Q1
$307K Buy
37,405
+12,000
+47% +$118K ﹤0.01% 1837
2024
Q4
$286K Sell
25,405
-9,140
-26% -$135K ﹤0.01% 1920
2024
Q3
$667K Buy
+34,545
New +$905K ﹤0.01% 1596

Other funds holding PIII

Corient Private Wealth's PIII Position: Q1 2026 in Review

Corient Private Wealth reduced its P3 Health Partners (PIII) stake by 52% in Q1 2026, selling an estimated $57.5K and leaving 19,837 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Corient Private Wealth first reported a position in PIII in Q3 2024 and has held it in 7 quarters since. The position peaked at $667K in Q3 2024. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • Corient Private Wealth held 19,837 shares of P3 Health Partners worth $61.1K as of Q1 2026.
  • Corient Private Wealth sold 21,837 P3 Health Partners shares in Q1 2026, an estimated $57.5K.
  • P3 Health Partners made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2745 holding.
  • Corient Private Wealth first reported a position in P3 Health Partners in Q3 2024 and has held it in 7 quarters since.
  • Corient Private Wealth's P3 Health Partners position peaked at $667K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.